
Selank + Semax is a combined nootropic research blend pairing the anxiolytic-studied Selank with the focus-studied Semax. Supplied for laboratory research use only.
This blend pairs two of the most-studied Russian-developed research peptides: Selank, a tuftsin analogue studied for anxiolytic-like activity, and Semax, an ACTH(4-10) analogue studied for nootropic and neuroprotective activity. The combination is of interest where calm and focus pathways are examined together.
Both peptides are reported to act on BDNF-linked neurotrophic signalling, with Selank additionally studied for GABAergic and enkephalin pathways and Semax for the melanocortin and dopaminergic systems.
| Area | Reported research focus |
|---|---|
| Stress & focus | Anxiolytic and attention pathways studied together. |
| Neuroplasticity | BDNF-linked signalling from both components. |
| Neuroprotection | Semax ischaemia / oxidative-stress models. |
| Specification | Detail |
|---|---|
| Product | Selank + Semax Blend |
| Format | Lyophilised vial or nasal spray |
| Fill | 10 mg |
| Purity | Specified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes |
| Price | €55.00 (vial) · €60.00 (nasal spray) |
| Availability | In stock — dispatched from Ireland within 1–2 working days, tracked |
| Supplied for | Laboratory research use only — not for human consumption, diagnostic or therapeutic use |
Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.
Occasional, useful email: new-batch and restock notices, the free reconstitution calculator and guides, plus FIRST10 for 10% off your first order. No daily blasts.